BSEBoard Meeting6 Aug 2026 · 6 Aug 2026, 05:35 pm
Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Financial result ....
Omkar Pharmachem Ltd · 532167
✦ AI SummaryResults
Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 to consider and approve Unaudited Financial result for the quarter ended on June 30, 2026 along with Limited Review Report thereof.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Omkar Pharmachem Ltd - 532167 - Board Meeting Intimation for Intimation Of The Board Meeting Of The Company Under Regulation 29(1)(A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
092cc3e4-42c9-4ca8-a641-eb426a4c871f.pdf
View document text
30 Ombkayr Phavmachem 4.
Date: 06.08.2026
BSE Limited,
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai-400001
Sub: Intimation of the Board Meeting of the Company Under Regulation
29(1)(A) of SEBI (Listing Obligations And Disclosure Requirements)
Regulations, 2015
Company Scrip Code: 532167
Dear Sir(s),
Pursuant to Regulations 29(1)(a) of SEBI (LODR) Regulations 2015 notice is
hereby given that a meeting of Board of Directors of Omkar Pharmachem
Limited will be held on Thursday, 13" Day of August, 2026 at 03:30 P.M. at
the registered office of the Company inter alia, to consider and approve:
1. Unaudited Financial result for the quarter ended on June 30, 2026 along with
Limited Review Report thereof.
Further, in continuation to our Intimation dated June 25, 2026 regarding closure
of trading window for dealing in shares of the Company, we hereby inform you
that pursuant to the Code of Conduct to Regulate, Monitor and Report Trading in
Securities of the Company, the trading window for dealing in shares of the
Company shall continue to remain closed till August 15, 2026, (inclusive) for all
the Designated Persons of the Company and their Immediate Relatives.
Thanking you,
Yours faithfully,
For Omkar Pharmachem Limited
BHAWAN i dcov
IS GOYA5L76Y w570
Bhawani S Goyal
(Managing Director)
DIN: 03255804
Address: Ward No-03, Nangal Chaudhry,
Narnaul, Mahendragarh, Haryana-123023
Reg. Off.: 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge Ahmedabad-380006, GJ, Ph.: 9711811163
CIN: L93000GJ1995PLC025276, Email: investors.opl@gmail.com, Website: www.omkarpharmachem.co.in